FIELD: biotechnology; virology.
SUBSTANCE: Ebola-Zaire virus strain ESMS 2020, adapted for guinea pigs, which has the ability to cause an expressed disease with the manifestation of hemorrhagic syndrome, is registered in the National Collection of Strains of hemorrhagic fever viruses of pathogenicity group I of the Federal State Budgetary Institution (FSBI) “48 Central Research Institute” (CRI) of the Ministry of Defense of the Russian Federation under the registration number NKV-26.
EFFECT: invention provides for preclinical testing of medical protective means against Ebola hemorrhagic fever.
3 cl, 6 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STRAIN OF EBOL VIRUS "ZAIR K-5" FOR CARRYING OUT MODEL EXPERIMENTS AND PREPARING DIAGNOSTIC AND VACCINE PREPARATIONS | 2001 |
|
RU2225439C2 |
| STRAIN OF EBOL VIRUS "ZAIR CH-5" FOR CARRYING OUT MODEL EXPERIMENTS AND PREPARING DIAGNOSTIC AND VACCINE PREPARATIONS | 2001 |
|
RU2225440C2 |
| METHOD OF INHIBITING INFECTIOUS ACTIVITY OF EBOLA VIRUS IN EXPERIMENT | 2015 |
|
RU2585695C1 |
| STRAIN C/2014 OF MACHUPO VIRUS - AGENT OF BOLIVIAN HAEMORRHAGIC FEVER INTENDED FOR LABORATORY EVALUATION OF EFFECTIVENESS OF MEDICAL REMEDIES IN RESPECT OF THIS PATHOGEN | 2017 |
|
RU2699525C2 |
| IMMUNOGEN PEPTIDES AND "EPIVAKEBOL" VACCINE AGAINST EBOLA FEVER WITH APPLICATION OF INDICATED PEPTIDES | 2017 |
|
RU2635998C1 |
| METHOD OF OBTAINING PURIFIED HETEROLOGOUS IMMUNOGLOBULIN AGAINST EBOLA FEVER | 2023 |
|
RU2815252C1 |
| VIRUS LASS STRAIN "SVINKA" DESIGNATED FOR LABORATORY EVALUATION OF EFFECTIVENESS OF MEDICINAL PROTECTION AGENTS | 2004 |
|
RU2274655C1 |
| EARLY DIAGNOSTIC TECHNIQUE FOR EBOLA HEMORRHAGIC FEVER IN INDIVIDUALS PRESUMABLY INFECTED WITH SUCH VIRUS | 2010 |
|
RU2450274C1 |
| STRAINS OF HYBRID CELLS OF ANIMALS MUS_ MUSCULUS - PRODUCERS OF MONOCLONAL ANTIBODIES TO PROTEIN GP OF EBOLA VIRUS (SUBTYPE ZAIRE) AND MONOCLONAL ANTIBODIES TO PROTEIN GP OF EBOLA VIRUS (SUBTYPE ZAIRE) | 2017 |
|
RU2686630C1 |
| HSOBIENS-WT/GIN/2015/KALIDIE-KINDIA-1022 STRAIN OF EBOLA ZAIRE TO OBTAIN ANTIGEN USED AS COMPONENT OF IMMUNOENZYMOMETRIC TEST SYSTEM FOR DETECTION OF G AND M ANTIBODIES TO VIRUS OF EBOLA | 2016 |
|
RU2631937C1 |
